G51 vs V5Z: Side-by-Side Comparison
Compare Genscript Biotech Corporation (G51) and Sirnaomics Ltd. (V5Z) side by side: market cap EUR 2.88B vs EUR 55.91M. Financials, growth and model signals on Bullrun.
| Metric | G51 | V5Z |
|---|---|---|
| Company | Genscript Biotech Corporation | Sirnaomics Ltd. |
| Country / Exchange | Hong Kong · F | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 2.88B | EUR 55.91M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 959.53M | EUR 1.78M |
| Revenue growth YoY | +61.4% | — |
| Net income | EUR -532.83M | EUR -51.38M |
| Gross margin | 57.7% | 67.4% |
| Diluted EPS | -0.25 | -0.66 |